Xu, Jian-ming <br/><br/>
[Experimental study of effect of epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in combination with irinotecan].  [electronic resource] 

 -  Zhonghua zhong liu za zhi [Chinese journal of oncology]  Aug 2006 
 - 578-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0253-3766 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>Apoptosis--drug effects<br/>Camptothecin--analogs & derivatives<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Colonic Neoplasms--enzymology<br/>DNA Topoisomerases, Type I--metabolism<br/>Drug Synergism<br/>ErbB Receptors--antagonists & inhibitors<br/>Gefitinib<br/>HT29 Cells<br/>Humans<br/>Inhibitory Concentration 50<br/>Irinotecan<br/>Mitogen-Activated Protein Kinase Kinases--metabolism<br/>Phosphorylation--drug effects<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Quinazolines--pharmacology<br/>Signal Transduction--drug effects